Stimulation of glyceraldehyde-3-phosphate dehydrogenase mRNA levels by endogenous nitric oxide in cytokine-activated endothelium

Biochem Biophys Res Commun. 1995 Dec 5;217(1):363-9. doi: 10.1006/bbrc.1995.2785.

Abstract

Previous studies have shown that endogenous nitric oxide (NO) potentiates glycolysis in the cytokine-activated murine microvascular endothelial cells (MME). In the present study we investigate the influence of NO on the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an enzyme of the glycolytic pathway. Activation of MME with TNF-alpha and IFN-gamma resulted in a strong elevation of GAPDH mRNA levels. This effect was impaired in the presence of L-NMMA, the inhibitor of NO synthesis. We discuss the possibility that NO-mediated elevation of GAPDH mRNA levels may compensate for NO-mediated inhibition of GAPDH enzymatic activity, representing another adaptive mechanism which protects cells producing large amounts of NO against its cytotoxic effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Cells, Cultured
  • Endothelium, Vascular / metabolism*
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics*
  • Glycolysis
  • Humans
  • Interferon-gamma / pharmacology
  • Mice
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism*
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology
  • omega-N-Methylarginine

Substances

  • RNA, Messenger
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • omega-N-Methylarginine
  • Nitric Oxide
  • Interferon-gamma
  • Arginine
  • Nitric Oxide Synthase
  • Glyceraldehyde-3-Phosphate Dehydrogenases